Overview
With a developing Pharmaceutical market that boasts a good fortune for foreign medicinal product and medical device manufacturers, Pakistan attracts significant investments in the region. To access the market, manufactures must obtain approvals from the Drug Regulatory Authority of Pakistan (DRAP), a regional health authority that regulates the manufacture, import, export, storage, distribution and sale of therapeutic goods. However, manufacturers must possess an expert hold of Regulatory affairs in the region to navigate the market for product market authorizations and drug approvals.
Aiming at redefining the Regulatory solutions and services globally with a specialized regional focus, Freyr assists manufacturers with the needed Regulatory consulting support in Pakistan and extends value-added Regulatory operations and Regulatory affairs support in the region. Freyr’s Regulatory Services in Pakistan span across:
- Medical Devices
- Pharmaceuticals
- OTC
- Biotech
Freyr Offerings
- Strategic Regulatory Consulting
- Regulatory Affairs & Regulatory intelligence,
- Registration pathways and license management services,
- Marketing authorization applications, renewals
Freyr Advantages
- Expert Regulatory team with proven global RA expertise
- Proactive and Collaborative approach
- Quick turnarounds and faster time-to-market
- Keeping abreast with region-specific legislation and Regulatory guidelines